Méndez-Martínez Marisol, Zamilpa Alejandro, Zavala-Sánchez Miguel A, Almanza-Pérez Julio C, Jiménez-Ferrer J Enrique, Herrera-Ruiz Maribel, González-Cortázar Manasés, Cervantes-Torres Jaquelynne, Fragoso Gladis, Rosas-Salgado Gabriela
División de Ciencias Biológicas y de la Salud, Departamento de Sistemas Biológicos, Universidad Autónoma Metropolitana, Mexico City, Mexico.
Facultad de Medicina, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, Mexico.
PLoS One. 2024 Aug 8;19(8):e0306903. doi: 10.1371/journal.pone.0306903. eCollection 2024.
Malva parviflora has shown anti-inflammatory, antihypertensive, antihyperlipidemic, and hypoglycemic effects. This study is aimed to evaluate the anti-adipogenic effect of M. parviflora on 3T3-L1 adipocytes. Fibroblast differentiation was induced either in the absence or presence of M. parviflora fractions (F3, F4, F7, F12, F13, F17, F18 and F19) for 4 days; F17 and 18 were the most effective fractions in reducing intracellular lipid accumulation (by 25.6% and 23.1%, respectively). EC50 of F17 and F18 (14 μg/mL and 17 μg/mL, respectively) were used to evaluate their anti adipogenic effect. After 10 days of inducing differentiation in the absence or presence of the extracts at the EC50 of F17 and F18, lipid accumulation, the concentration of interleukin 6 (IL-6) were measured in the culture medium; the presence of PPAR-γ, AKT, and p-AKT was also determined. In differentiated adipocytes (C2), F17 maintained intracellular lipid concentration at levels comparable to metformin, while decreasing PPAR-γ and increasing p-AKT presence; it also prevented IL-6 expression. F17 consists of alanine, valine, phenylalanine, and proline. On the other hand, F18 reduced intracellular lipid concentrations, prevented the increase of PPAR-γ and p-AKT, and maintained IL-6 expression at similar levels as metformin. F18 is mainly constituted by alanine, valine, proline, and sucrose. In conclusion, M. parviflora fractions (F17 and F18) control the process of adipogenesis, lipogenesis, and cellular dysfunction.
小花锦葵已显示出抗炎、降压、抗高血脂和降血糖作用。本研究旨在评估小花锦葵对3T3-L1脂肪细胞的抗脂肪生成作用。在不存在或存在小花锦葵组分(F3、F4、F7、F12、F13、F17、F18和F19)的情况下诱导成纤维细胞分化4天;F17和F18是减少细胞内脂质积累最有效的组分(分别减少25.6%和23.1%)。F17和F18的半数有效浓度(EC50)(分别为14μg/mL和17μg/mL)用于评估它们的抗脂肪生成作用。在不存在或存在F17和F18的EC50提取物的情况下诱导分化10天后,测量培养基中的脂质积累、白细胞介素6(IL-6)浓度;还测定了过氧化物酶体增殖物激活受体γ(PPAR-γ)、蛋白激酶B(AKT)和磷酸化蛋白激酶B(p-AKT)的存在情况。在分化的脂肪细胞(C2)中,F17将细胞内脂质浓度维持在与二甲双胍相当的水平,同时降低PPAR-γ并增加p-AKT的存在;它还抑制IL-6表达。F17由丙氨酸、缬氨酸、苯丙氨酸和脯氨酸组成。另一方面,F18降低细胞内脂质浓度,阻止PPAR-γ和p-AKT增加,并将IL-6表达维持在与二甲双胍相似的水平。F18主要由丙氨酸、缬氨酸、脯氨酸和蔗糖组成。总之,小花锦葵组分(F17和F18)控制脂肪生成、脂质生成和细胞功能障碍的过程。